Alex Rodriguez meets with MLB investigators to discuss relationship with Canadian doctor

By Ronald Blum, AP
Friday, April 2, 2010

A-Rod meets with MLB investigators on Canadian Dr.

NEW YORK — Alex Rodriguez has met with three officials from Major League Baseball and told them he didn’t receive performance-enhancing drugs from a Canadian doctor under federal investigation.

Rodriguez met Thursday in the Tampa area with Dan Mullin, baseball’s vice president of investigations; Victor Burgos, who works in Mullin’s department; and Dan Halem, a senior vice president in baseball’s labor relations department.

The New York Yankees third baseman was accompanied by lawyers James Sharp and Jay Reisinger. Details were disclosed by a person familiar with the meeting who spoke on condition of anonymity because no announcements were authorized.

The Canadian doctor, Anthony Galea, told The Associated Press last month that he only prescribed anti-inflammatories to Rodriguez.

THIS IS A BREAKING NEWS UPDATE. Check back soon for further information. AP’s earlier story is below.

TAMPA, Fla. (AP) — Alex Rodriguez met with officials from Major League Baseball on Thursday to discuss his relationship with a Canadian doctor who is under federal investigation in a drug case.

“It went well. I cooperated,” Rodriguez said Friday. “They were very happy.”

The New York Yankees slugger was expected to first meet with federal agents about Dr. Anthony Galea, who faces four charges in Canada related to human growth hormone and Actovegin, before meeting with baseball officials.

The FBI in Buffalo, N.Y., had no comment.

Rodriguez and federal agents were supposed to meet March 26 in western New York, but the interview was canceled by mutual consent. A-Rod on Friday would not discuss the federal probe.

“I’m not really allowed to get into any of that,” Rodriguez said.

Galea told The Associated Press in an interview March 8 he prescribed anti-inflammatories for Rodriguez, not HGH, after the third baseman had hip surgery last year.

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :